Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 251

Results For "IT"

10364 News Found

LG Chem inks deal with Innovent Biologics for gout treatment candidate
News | December 15, 2022

LG Chem inks deal with Innovent Biologics for gout treatment candidate

LG Chem will receive totaling up to $95.5 million for the China rights


Balaxi conducts groundbreaking for its Rs 85 crore Hyderabad manufacturing facility
News | December 14, 2022

Balaxi conducts groundbreaking for its Rs 85 crore Hyderabad manufacturing facility

The investment will enable the company to enter European markets as well as enhance margins in current markets


US Federal Court dismisses cancer linkage associated with Zantac
News | December 13, 2022

US Federal Court dismisses cancer linkage associated with Zantac

The current ruling will assure the safety of the use of Ranitidine for Indian patients


Peter Bains appointed Additional Director of Biocon
People | December 13, 2022

Peter Bains appointed Additional Director of Biocon

He has global experience in strategic and operational leadership including at Board, CEO and Senior Corporate levels


Alembic receives EIR for oncology injectable formulation facility at Panelav
Drug Approval | December 12, 2022

Alembic receives EIR for oncology injectable formulation facility at Panelav

This was a pre-approval inspection to cover our Oncology Injectable drug products for which ANDAs were filed with USFDA


PM lays foundation stone for National Institute for One Health in Nagpur
Policy | December 12, 2022

PM lays foundation stone for National Institute for One Health in Nagpur

The Institute will focus on increasing preparedness and laboratory capabilities for identification of novel and unknown zoonotic agents


Progress under “PM Surakshit Matritva Abhiyan”
Policy | December 12, 2022

Progress under “PM Surakshit Matritva Abhiyan”

Since inception, more than 3.6 crore pregnant women have received comprehensive ANC under this programme across all states and UTs


GSK’s new data underscore important responses with momelotinib for myelofibrosis patients
Clinical Trials | December 12, 2022

GSK’s new data underscore important responses with momelotinib for myelofibrosis patients

48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response


Aster DM Healthcare and Faruk Medical City to develop healthcare services in Iraq
Healthcare | December 08, 2022

Aster DM Healthcare and Faruk Medical City to develop healthcare services in Iraq

Aster DM Healthcare and Faruk Medical City will jointly provide training and academic support to medical and paramedical staff


Cadila Pharmaceuticals signs IIF with Odisha Government
News | December 08, 2022

Cadila Pharmaceuticals signs IIF with Odisha Government

The company will set-up a pharmaceuticals formulation manufacturing unit with an investment of Rs. 100 crore in Odisha